エディションの選択
国
重点項目
病状
組織の種類
ステークホルダー
品質
Third Edition BOGP (10)
Advocacy (policy advocacy, lobbying)
Pharmaceutical, Biotech, Medical Device Company (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Health Technology Assessment (HTA) activities